TSC research including Research Round Up – a quarterly summary of some of the most important TSC-related research from Australia and around the world.
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial (Online release) Released online this week, the EXIST-1 team have published long term safety data of the … Read More
Information from the clinical trials team at Sydney Children’s Hospital for families interested in participating in research into the topical use of rapamycin to treat angiofibromas.
Three years of fundraising has led to Sydney Children’s Hospital being funded by ATSS to take part in the first randomized controlled trial for the topical use of Rapamycin for angiofibromas, the skin condition that affects up to 90% of people with Tuberous Sclerosis Complex. Thank you to the hundreds of people that organized fundraising activities and donated. Over $200,000 was raised; however, the average donation was under $100.